If you’re thinking about buying an unprofitable company, you need to keep two things in mind. First, the business needs to have a plan to eventually produce consistent and positive cash flows if it ever wants to convince the market that its stock is worth buying. And second, picking up a stock well before its future is secure is risky, but it also offers chances for significant gain.
In that vein, Tilray (NASDAQ: TLRY) is a Canadian cannabis business that has a plan to become profitable but is still facing a big wildcard in the near future. In fact, buying the stock today could lead to a dramatically different return than buying it at the end of the month. Should investors take a calculated risk by buying early in April, or would it be better to wait a few more weeks — or perhaps a few quarters?